Atomistry » Zinc » PDB 6a3n-6aem » 6a3n
Atomistry »
  Zinc »
    PDB 6a3n-6aem »
      6a3n »

Zinc in PDB 6a3n: Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2

Enzymatic activity of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2

All present enzymatic activity of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2:
3.1.4.35;

Protein crystallography data

The structure of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2, PDB code: 6a3n was solved by Y.N.Wu, Q.Zhou, Y.P.Chen, H.B.Luo, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 25.46 / 2.60
Space group P 41 21 2
Cell size a, b, c (Å), α, β, γ (°) 104.110, 104.110, 269.079, 90.00, 90.00, 90.00
R / Rfree (%) 24.8 / 28

Other elements in 6a3n:

The structure of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2 also contains other interesting chemical elements:

Fluorine (F) 2 atoms
Magnesium (Mg) 2 atoms

Zinc Binding Sites:

The binding sites of Zinc atom in the Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2 (pdb code 6a3n). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2, PDB code: 6a3n:
Jump to Zinc binding site number: 1; 2;

Zinc binding site 1 out of 2 in 6a3n

Go back to Zinc Binding Sites List in 6a3n
Zinc binding site 1 out of 2 in the Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn601

b:51.9
occ:1.00
O A:HOH703 2.0 51.5 1.0
O A:HOH701 2.0 38.3 1.0
OD2 A:ASP293 2.0 31.9 1.0
OD1 A:ASP402 2.0 33.3 1.0
NE2 A:HIS292 2.1 35.4 1.0
NE2 A:HIS256 2.2 39.7 1.0
CE1 A:HIS292 3.1 32.7 1.0
CD2 A:HIS292 3.1 31.9 1.0
CG A:ASP402 3.1 27.8 1.0
CE1 A:HIS256 3.1 34.9 1.0
CD2 A:HIS256 3.2 35.5 1.0
CG A:ASP293 3.2 26.0 1.0
OD2 A:ASP402 3.6 28.3 1.0
OD1 A:ASP293 3.8 26.9 1.0
MG A:MG602 3.9 28.3 1.0
CD2 A:HIS252 4.0 24.2 1.0
ND1 A:HIS292 4.2 31.7 1.0
NE2 A:HIS252 4.2 24.5 1.0
CG A:HIS292 4.2 29.6 1.0
ND1 A:HIS256 4.2 32.9 1.0
CG A:HIS256 4.3 32.3 1.0
O A:HOH705 4.3 22.7 1.0
CB A:ASP293 4.4 24.1 1.0
O A:ASP402 4.4 27.7 1.0
CB A:ASP402 4.4 26.7 1.0
O A:HOH702 4.5 26.8 1.0
O A:HOH737 4.5 27.4 1.0
CA A:ASP402 4.7 25.8 1.0
CG2 A:VAL260 4.7 21.6 1.0
C A:ASP402 5.0 26.8 1.0
O A:HOH772 5.0 26.9 1.0

Zinc binding site 2 out of 2 in 6a3n

Go back to Zinc Binding Sites List in 6a3n
Zinc binding site 2 out of 2 in the Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Crystal Structure of the PDE9 Catalytic Domain in Complex with Inhibitor 2 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Zn601

b:44.1
occ:1.00
O B:HOH707 2.0 47.1 1.0
O B:HOH702 2.0 31.1 1.0
OD2 B:ASP293 2.0 28.6 1.0
OD1 B:ASP402 2.0 32.1 1.0
NE2 B:HIS292 2.1 30.1 1.0
NE2 B:HIS256 2.1 36.0 1.0
CD2 B:HIS292 3.1 27.2 1.0
CE1 B:HIS256 3.1 33.6 1.0
CG B:ASP402 3.1 26.7 1.0
CE1 B:HIS292 3.1 27.4 1.0
CG B:ASP293 3.1 24.3 1.0
CD2 B:HIS256 3.1 32.8 1.0
OD2 B:ASP402 3.6 26.7 1.0
OD1 B:ASP293 3.8 24.1 1.0
MG B:MG602 3.9 22.3 1.0
O B:HOH723 4.0 23.0 1.0
ND1 B:HIS292 4.2 26.3 1.0
ND1 B:HIS256 4.2 32.2 1.0
CG B:HIS292 4.2 25.3 1.0
CB B:ASP293 4.3 23.2 1.0
CD2 B:HIS252 4.3 22.4 1.0
CG B:HIS256 4.3 30.5 1.0
CB B:ASP402 4.4 25.7 1.0
O B:HOH701 4.5 20.8 1.0
NE2 B:HIS252 4.5 22.3 1.0
O B:ASP402 4.7 23.3 1.0
CA B:ASP402 4.7 23.9 1.0
CG2 B:VAL260 4.8 21.3 1.0
O B:HOH738 4.9 20.1 1.0
O B:HOH733 4.9 18.5 1.0

Reference:

Y.Wu, Q.Zhou, T.Zhang, Z.Li, Y.P.Chen, P.Zhang, Y.F.Yu, H.Geng, Y.J.Tian, C.Zhang, Y.Wang, J.W.Chen, Y.Chen, H.B.Luo. Discovery of Potent, Selective, and Orally Bioavailable Inhibitors Against Phosphodiesterase-9, A Novel Target For the Treatment of Vascular Dementia. J. Med. Chem. V. 62 4218 2019.
ISSN: ISSN 1520-4804
PubMed: 30916555
DOI: 10.1021/ACS.JMEDCHEM.8B01041
Page generated: Mon Oct 28 17:15:58 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy